Joao MD Siffert's Net Worth
$1.43 Million
Who is Joao MD Siffert?
Joao MD Siffert has an estimated net worth of $1.43 Million. This is based on reported shares across multiple companies, which include Design Therapeutics, Inc., AveXis, Inc., ABEONA THERAPEUTICS INC., and AVANIR PHARMACEUTICALS, INC..
SEC CIK
Joao MD Siffert's CIK is 0001534986
Past Insider Trading and Trends
2014 was Joao MD Siffert's most active year for acquiring shares with 5 total transactions. Joao MD Siffert's most active month to acquire stocks was the month of November. 2014 was Joao MD Siffert's most active year for disposing of shares, totalling 6 transactions. Joao MD Siffert's most active month to dispose stocks was the month of April. 2014 saw Joao MD Siffert paying a total of $83,633.69 for 250,097 shares, this is the most they've acquired in one year. In 2014 Joao MD Siffert cashed out on 99,520 shares for a total of $758,375.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Design Therapeutics, Inc. (DSGN) Snapshot price: $2.3
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +5.95% | 7.45K |
$8.39 | $62,503.00 | 132.62K |
Dec 19 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AveXis, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.11K |
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 1.11K |
—
|
—
| 1.11K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ABEONA THERAPEUTICS INC. (ABEO) Snapshot price: $4.52
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 100K |
—
|
—
| 100K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31 - Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS, INC. No price found
SVP, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.76% | -2.42K |
$9.78 | -$505,141.92 | 314.19K |
Scheduled
|
Dec 18
| ||
Form 4
| +42.26% | 94.06K |
—
|
—
| 316.61K |
Nov 10
| |||
Form 4
| -3.65% | -8.43K |
$11.80 | -$99,426.80 | 222.55K |
Scheduled
|
Oct 24
| ||
Form 4
| -5.54% | -13.55K |
$5.18 | -$70,173.46 | 230.98K |
May 28
| |||
Form 4
| +112.27% | 123.75K |
—
|
—
| 233.98K |
Feb 12
| |||
Form 4
| -5.14% | -5.97K |
$2.63 | -$15,713.04 | 110.23K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
$3.04 | -$49,944.26 | 116.2K |
Scheduled
|
Sep 18
| ||
Form 4
| +260.87% | 84K |
—
|
—
| 116.2K |
Dec 17
| |||
Form 4
| +9.15% | 2.7K |
$2.96 | $7,992.00 | 32.2K |
May 10
| |||
Form 4
|
∞
| 29.5K |
—
|
—
| 29.5K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||